Company: GLPG
Filing Date: 2025-03-27
Form Type: 20-F
Source: 0001558370-25-003806
Chunk: 228

Company: GALAPAGOS NV
Filing Date: 2025-03-27
Form: 20-F
Item: Item 6
Chunk 228
---
 a set period of time after receipt of such cash remuneration. The shares that each Director so acquires must be held until at least one year after the Director leaves the Board of Directors and at least three years after the time of acquisition. This additional cash compensation constitutes the equivalent o the equity component of the members of the Board of Directors' remuneration, as recommended by section 7.6 of the 2020 Corporate Governance Code.                               
(2) On the annual Shareholders' Meeting of April 30, 2024, the shareholders approved that the annual compensation (excluding expenses) of the Non-Executive Directors, other than the Non-Executive Directors representing a shareholder, for the exercise of their mandate shall be increased as of May 1, 2024 and consist of a cash remuneration and an equity-based remuneration as set out in the above table.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
(3) The Chair fees were not payable for financial year 2024 as the CEO is only remunerated for the performance of his executive functions as CEO and is not entitled to any additional remuneration for his mandates of Chair of the Board of Directors and Committee member.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
(4) Given his function and responsibilities, the Lead Non-Executive Director receives an increased compensation as of May 1, 2024. Before the Lead Non-Executive Director received the same remuneration as the other Non-Executive Directors.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
​
In accordance with our Remuneration Policy and the decisions of the Annual Shareholders' Meeting of April 28, 2020 and the Annual Shareholders’ Meeting of April 30, 2024, the effective remuneration of the members of the Board of Directors, other than the Board members representing a shareholder, for the exercise of their mandate during the financial year ending December 31, 2024 is as follows:
(a) fixed cash remuneration: (i) Chair of the Board of Directors (i.e. Stoffels IMC BV, permanently represented by Dr. Paul Stoffels: N/A ; (ii) other Non-Executive members of the Board of Directors (i.e. Peter Guenter, Elisabeth Svanberg, Dan Baker (until October 6, 2024), Jérôme Contamine, Susanne Schaffert, and Simon Sturge: €50,000 each until April 30,2024 and €55,000 each as of May